# Study on the Role and Mechanism of TOPORS in Regulating Aortic Dissection by Mediating SUMOylation

**Authors:** Yuan Hu, Luxi Yang, Wenjun Zhou, Hao Chen, Yuanmin Li, Bing Song, Cuntao Yu

PMC · DOI: 10.3390/jcdd13030110 · Journal of Cardiovascular Development and Disease · 2026-02-27

## TL;DR

This study explores how TOPORS regulates aortic dissection through SUMOylation, showing that TOPORS promotes inflammation and cell death, worsening the condition.

## Contribution

The study reveals a novel role of TOPORS in aortic dissection via SUMOylation of p53, linking it to inflammation and cell apoptosis.

## Key findings

- TOPORS inhibition reduces aortic dilation and elastic fiber degradation in AD models.
- TOPORS suppression decreases inflammatory cytokines and promotes PI3K/AKT phosphorylation.
- TOPORS-mediated SUMOylation of p53 contributes to vascular smooth muscle cell apoptosis and AD progression.

## Abstract

Aortic dissection (AD) is a fatal acute cardiovascular emergency. SUMOylation participates in cell proliferation, apoptosis, and inflammation, but its role in AD, especially via TOPORS, remains unclear. This study investigates how TOPORS regulates AD pathogenesis through SUMOylation. AD and normal aortic samples were collected to detect TOPORS expression. AD mouse and VSMCs models were constructed to assess TOPORS depletion and overexpression effects on AD progression. In AD aortic tissues, TOPORS expression was upregulated, while tripartite motif containing 27 (TRIM27) and Sentrin-specific protease 6 (SENP6) expression showed no significant change. In vivo and in vitro experiments demonstrated that inhibition of TOPORS alleviated aortic dilation and elastic fiber degradation. TOPORS knockout suppressed the secretion of inflammatory cytokines (TNF-α, IL-1β, IL-6, and IFN-α), promoted PI3K/AKT phosphorylation, and downregulated p53 signaling. The p53 inhibitor PFTα reduced AD-induced cell apoptosis and upregulation of inflammatory cytokines. Co-immunoprecipitation further confirmed that inhibition of TOPORS decreases SUMOylation of p53. Conclusions: TOPORS activates p53, inhibits PI3K/AKT phosphorylation via SUMOylation, promotes vascular smooth muscle cell (VSMC) apoptosis and inflammation, and exacerbates AD pathogenesis.

## Linked entities

- **Genes:** TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase) [NCBI Gene 10210], TRIM27 (tripartite motif containing 27) [NCBI Gene 5987], SENP6 (SUMO specific peptidase 6) [NCBI Gene 26054], TP53 (tumor protein p53) [NCBI Gene 7157], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase), TRIM27 (tripartite motif containing 27), SENP6 (SUMO specific peptidase 6), TP53 (tumor protein p53), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6), IFN1@ (interferon, type 1, cluster)
- **Chemicals:** PFTα (PubChem CID 9929138)

## Full-text entities

- **Genes:** SUMO1 (small ubiquitin like modifier 1) [NCBI Gene 7341] {aka DAP1, GMP1, OFC10, PIC1, SMT3, SMT3C}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Sumo1 (small ubiquitin-like modifier 1) [NCBI Gene 22218] {aka GMP1, PIC1, SENTRIN, SMT3, SMT3H3, SMTP3}, Trim27 (tripartite motif-containing 27) [NCBI Gene 19720] {aka Gm19403, Rfp}, Ncf1 (neutrophil cytosolic factor 1) [NCBI Gene 17969] {aka NCF-47K, NOXO2, Ncf-1, p47-phox, p47<phox>, p47phox}, Senp6 (SUMO/sentrin specific peptidase 6) [NCBI Gene 215351] {aka 2810017C20Rik, E130319N12Rik, Susp1, mKIAA0797}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, Esr1 (estrogen receptor 1 (alpha)) [NCBI Gene 13982] {aka ER, ER-alpha, ERa, ERalpha, ESR, Estr}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Ccdc80 (coiled-coil domain containing 80) [NCBI Gene 67896] {aka 2610001E17Rik, DRO1, Ssg1, Urb}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase) [NCBI Gene 10210] {aka LUN, P53BP3, RP31, TP53BPL}, Fgfr1 (fibroblast growth factor receptor 1) [NCBI Gene 14182] {aka Eask, FGFR-I, FLG, Fgfr-1, Flt-2, Fr1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Trim39 (tripartite motif-containing 39) [NCBI Gene 79263] {aka 1100001D15Rik, E130103K13Rik, RBCC-B30.2, Rnf23, mKIAA4179, tfp}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TRIM27 (tripartite motif containing 27) [NCBI Gene 5987] {aka RFP, RNF76}, Hey1 (hairy/enhancer-of-split related with YRPW motif 1) [NCBI Gene 15213] {aka CHF2, HRT1, Herp2, Hesr1, bHLHb31, hesr-1}, TAGLN (transgelin) [NCBI Gene 6876] {aka SM22, SM22-alpha, SMCC, TAGLN1, TGLN, WS3-10}, Ube2i (ubiquitin-conjugating enzyme E2I) [NCBI Gene 22196] {aka 5830467E05Rik, UBC9, Ubce2i, Ubce9}, Srf (serum response factor) [NCBI Gene 20807], Topors (topoisomerase I binding, arginine/serine-rich) [NCBI Gene 106021] {aka LUN, TP53BPL, p53BP3, p53BP3/LUN}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Ackr1 (atypical chemokine receptor 1 (Duffy blood group)) [NCBI Gene 13349] {aka CCBP1, CD234, Darc, Dfy, ESTM35, FY}, Ctrl (chymotrypsin-like) [NCBI Gene 109660] {aka 0910001G08Rik, 1810004D15Rik, Ctra-1, Ctra1, chymopasin, mFLJ00366}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Ifna (interferon alpha complex region) [NCBI Gene 111654] {aka Ifa, Ifa8}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, SENP6 (SUMO specific peptidase 6) [NCBI Gene 26054] {aka SSP1, SUSP1}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}
- **Diseases:** aortic injury (MESH:D001018), neurodegenerative diseases (MESH:D019636), inflammatory cytokines (MESH:D000080424), cardiovascular diseases (MESH:D002318), aortic dilation (MESH:D002311), tumorigenesis (MESH:D063646), injury to (MESH:D014947), neointimal hyperplasia (MESH:D006965), thoracic aortic aneurysmal enlargement (MESH:D017545), Inflammation (MESH:D007249), mycoplasma (MESH:D009175), aortic aneurysm (MESH:D001014), AD (MESH:D000784), tissue injury (MESH:D017695), rupture (MESH:D012421)
- **Chemicals:** xylene (MESH:D014992), BAPN (MESH:D000629), PFA (MESH:C003043), PI (MESH:D011419), 5-ethynyl-2'-deoxyuridine (MESH:C031086), eosin (MESH:D004801), DAPI (MESH:C007293), SDS (MESH:D012967), FITC (MESH:D016650), DAB (MESH:C000469), ethanol (MESH:D000431), Triton X-100 (MESH:D017830), sodium pentobarbital (MESH:D010424), Lipofectamine 2000 (MESH:C086724), streptomycin (MESH:D013307), PVDF (MESH:C024865), Orange G (MESH:C008710), PFT-alpha (MESH:C121565), CCK-8 (-), agarose (MESH:D012685), Hoechst 33342 (MESH:C017807), nitrogen (MESH:D009584), CO2 (MESH:D002245), hematoxylin (MESH:D006416), N-Ethylmaleimide (MESH:D005033), penicillin (MESH:D010406), H&amp;E (MESH:D006371), PBS (MESH:D007854), Paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Mycoplasma (genus) [taxon 2093]
- **Mutations:** C0171A, P0013C
- **Cell lines:** vascular smooth muscle — Homo sapiens (Human), Finite cell line (CVCL_4009), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026605/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026605/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026605/full.md

---
Source: https://tomesphere.com/paper/PMC13026605